Laurie J. Olson - 15 Aug 2022 Form 4/A - Amendment Insider Report for Karuna Therapeutics, Inc.

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Aug 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
12 Oct 2022, 17:04:45 UTC
Date Of Original Report
16 Aug 2022
Previous filing
16 Jun 2022
Next filing
12 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -1,000 -5.6% $0.000000 17,000 15 Aug 2022 Common Stock 1,000 $84.86 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020.
F2 This Form 4/A amends the Form 4 filed by the reporting person on August 16, 2022 (the "Original Form 4"), which inadvertently reported the incorrect number of securities in column 9 of Table II. This Form 4/A is being filed solely to correct the number of securities reported in column 9 of Table II. No other amendments or changes have been made to the Original Form 4.